Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.

1. In a cross-over study a new low molecular weight heparinoid Org 10172 was administered to 12 elderly male and female volunteers. It was well tolerated and no adverse effects occurred. 2. The absolute bioavailability of Org 10172 as measured by plasma anti-Xa activity, glycosaminoglycuronans with...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Stiekema, J C, Wijnand, H P, Van Dinther, T G, Moelker, H C, Dawes, J, Vinchenzo, A, Toeberich, H
Format: Artigo
Jezik:Inglês
Izdano: 1989
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1379703/
https://ncbi.nlm.nih.gov/pubmed/2468354
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items